MedPath

An invivo study to evaluate the effect of Platelet Rich Fibrin on dental implant stability when it is used as a filler in implant socket so as to modify the implant surface by using Radio Frequency Analysis.

Phase 2
Conditions
Health Condition 1: null- Patients with one or more missing teeth who choose to get replacement of missing teeth with dental implants.Patient should be fit to get treated with implants as specified in the inclusion criteria.
Registration Number
CTRI/2014/06/004684
Lead Sponsor
Dr Shashi Bhushan Gupta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Ability to understand and sign the informed consent before starting the study.

-Systemically healthy (ASA I or II).

-Adequate oral hygiene standards.

-One or more missing tooth, with the existing teeth being healthy or adequately treated.

Exclusion Criteria

-Severe bruxism or clenching habits.

-Untreated periodontitis.

-Tooth extraction or surgery in the concerned area in the preceding 6 months.

-Presence of local inflammation or mucosal diseases.

-Patient at a high risk for bacterial endocarditis.

-Physical handicap that would interfere with the patientâ??s ability to exercise good oral hygiene on a regular basis.

-Use of any investigational drug or device within the 30-day period immediately before implant therapy.

-Heavy smokers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Implant Stabilitty Quotient (ISQ)increases in experimental group (with PRF)thus showing enhanced implant stability in the same duration of time as compared with control.Timepoint: Baseline(at the time of initial surgery), 8 weeks, 16 weeks
Secondary Outcome Measures
NameTimeMethod
Osseointegration of implant with the alveolar bone.Timepoint: Baseline(at the time of initial surgery), 8 weeks, 16 weeks
© Copyright 2025. All Rights Reserved by MedPath